Results 181 to 190 of about 1,396,394 (289)

Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background The identification of Parkinson's disease (PD) subtypes is crucial for predicting the disease course and designing personalized therapeutic strategies. Objectives The aim of the study was to characterize the heterogeneity of the spatiotemporal evolutionary patterns of striatal dopamine depletion and cerebral hypoperfusion in PD ...
Yeeun Sun, Youngseok Choi, Chan Wook Park, Han Kyu Na, Hye Sun Lee, Yun Joong Kim, Young H. Sohn, Phil Hyu Lee, Jeyeon Lee, Seok Jong Chung   +9 more
wiley   +1 more source

Validity and reliability of the Hebrew version of the Brief Questionnaire of Olfactory Disorders (Brief-QOD) and the Self-Reported Mini Olfactory Questionnaire (Self-MOQ). [PDF]

J Patient Rep Outcomes
Hefetz T, Kassem F, Biadsee A, Hummel T, Hummel T, Blau I, Gershnabel-Milk D.   +6 more
europepmc   +1 more source

Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders. [PDF]

Chem Senses, 2023
Hunter SR, Hannum ME, Pellegrino R, O'Leary MA, Rawson NE, Reed DR, Dalton PH, Parma V.   +7 more
europepmc   +1 more source

Olfactory Nerve Disorder [PDF]

, 2020
openaire   +1 more source

Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Concurrent Alzheimer's disease pathology is increasingly recognized as a poor prognostic factor in Parkinson's disease (PD), yet reliable clinical indicators for early identification of AD copathology remain poorly established.
Han Kyu Na, Yeeun Sun, Chan Wook Park, Jung Hyun Lee, Yun Young Choi, Quynh Phuong Vo, Seok Jong Chung, Han Soo Yoo, Chul Hyoung Lyoo, Young H. Sohn, Jin Yong Hong, Phil Hyu Lee   +11 more
wiley   +1 more source

Propriety of various examinations for subjective symptoms of olfactory disorders. [PDF]

Eur Arch Otorhinolaryngol
Hemmi T, Nomura K, Kobayashi Y, Numano Y, Ikeda R, Sugawara M.   +5 more
europepmc   +1 more source

Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic. [PDF]

Pathogens, 2023
Saussez S, Vaira LA, De Riu G, Lechien JR.   +3 more
europepmc   +1 more source

Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine

Medicinal Research Reviews, EarlyView.
ABSTRACT Glycogen synthase kinase‐3 (GSK‐3) is a central regulator of numerous cellular signaling pathways, with critical roles in metabolism, proliferation, differentiation, and tissue regeneration. This review explores the multifaceted effects of pharmacological GSK‐3 inhibition across multiple body districts, focusing on its highly context‐dependent
Davide Schiroli, Alessia Merra, Chiara Marraccini, Lucia Merolle, Graziella Pellegrini, Eleonora Maurizi   +5 more
wiley   +1 more source

Validation of the questionnaire of olfactory disorders (QOD) for the Brazilian population. [PDF]

Clinics (Sao Paulo)
Bernardino ABCDS, Barreto-Filho MA, Pompeu AS, Andrade JDS, Azevedo ACA, Brasil MQA, Cedro M, Araújo C, Andrade N, Akrami K, Scussiatto HO, Boaventura VS, Fornazieri MA.   +12 more
europepmc   +1 more source

Investigating olfactory disorders in children with COVID-19 disease admitted to Hazrat Masoumeh Hospital in Qom. [PDF]

J Educ Health Promot, 2022
Alizadeh N, Hajian H, Movahedi Z, Agha Ali M.   +3 more
europepmc   +1 more source